Transparency Market

Research
Prenatal and New-born Genetic
Testing Market is growing at a
CAGR of 26.9% fro 2!"# to
2!"9. $% Trans&arenc% Market
Researc'.
Single User License:
USD 4595
Multi User License:
USD 7595
Corporate User License:
USD 10595
Prenatal and New-born Genetic Testing Market is growing
at a CAGR of 26.9% fro 2!"# to 2!"9. $% Trans&arenc%
Market Researc'.
Transparency Market Research
(tate Tower)
9!) (tate (treet) (*ite +!!.
Alban%) N, "22!+
-nited (tates
www.trans&arenc%arketresearc'.co
sales.trans&arenc%arketresearc'.co
87 Page Report
Publise! Date
"1#Marc#"014
$u% &o'
Re(uest Sa)ple
Press Release
Prenatal and New-
born Genetic Testing
Market
Prenatal and New-born Genetic Testing Market valued USD 1.12 billion in 2013 and expected to grow at a
CAGR of 2.!" fro# 2013 to 201!$ to reac% an e&ti#ated value of USD '.3( billion in 201!.
)renatal and newborn genetic te&ting i& referred to t%e utili*ation of &creening+diagno&tic
procedure& for a fetu& or a new born bab, to detect c%ro#o&o#al abnor#alitie& &uc% a& Down
&,ndro#e$ )atau &,ndro#e and -dward &,ndro#e. .%e&e te&ting procedure& enable detection of
certain genetic abnor#alitie& in a& earl, a& ' to 10 wee/& of ge&tation and al&o %elp to
deter#ine t%e &ex of t%e fetu&. According to 0ort%we&tern 1edical 2acult, 2oundation$ Down
&,ndro#e$ open neural tube defect& and tri&o#, 1' are t%e birt% defect& t%at '3" of wo#en are
advi&ed to be &creened or te&ted during pregnanc,. 4%erea&$ t%ere are &o#e te&t& w%ic%
provide& infor#ation about tri&o#, 13 and ot%er c%ro#o&o#e abnor#alitie&. )renatal and
newborn genetic te&t& are of two t,pe&$ diagno&tic and &creening te&t&. Diagno&tic te&t& %elp& to
con5r# t%e pre&ence of certain genetic condition& in a fetu& or a new born bab,$ w%ile &creening
te&t& detect& t%e c%ance of develop#ent of certain genetic abnor#alitie& in a fetu& or new born
bab,.
6row&e Global )renatal and 0ewborn Genetic .e&ting 1ar/et Report wit% 2ull .7C at
%ttp8++www.tran&parenc,#ar/etre&earc%.co#+prenatal9new9born9genetic9te&ting.%t#l
.%e prenatal and newborn genetic te&ting #ar/et i& driven b, increa&ing #aternal age and late
pregnancie&$ tec%nological advance#ent& and growing awarene&& about genetic di&order& in t%e
fetu&. :t wa& al&o ob&erved t%at t%e prenatal and newborn genetic te&ting #ar/et i& &till at a
na&cent &tage and %ave #an, opportunitie& &uc% a& capitali*ing on potential #ar/et& in t%e
e#erging A&ian$ African and ;atin A#erican countrie&.
:n diagno&tic tec%ni<ue& #ar/et$ pol,#era&e c%ain reaction =)CR> &eg#ent accounted for t%e
large&t &%are$ a& co#pared to 2:S? and aCG?. .%e )CR #ar/et i& #ainl, driven b, ri&ing
incidence& of genetic di&ea&e& and foren&ic& coupled wit% %ig% proce&& e@cienc,$ better
preci&ion and reliabilit, of t%e tec%ni<ue$ and a#pli5cation. 0on9inva&ive prenatal te&ting =0:).>
i& t%e large&t #ar/et &eg#ent in &creening #et%od and i& expected to grow at %ig%e&t CAGR of
3(." fro# 2013 to 201!.
Trans&arenc% Market Researc'
2
R*P+R, D*SCR-P,-+&
Prenatal and New-
born Genetic Testing
Market
.%e 0ort% A#erican region accounted for t%e large&t &%are of t%e total prenatal and newborn
genetic te&ting #ar/et. 7ne of t%e /e, factor& driving t%e growt% of 0ort% A#erica #ar/et i& t%e
non9inva&ive nature of t%e te&t t%at co#pletel, eli#inate& t%e ri&/ of #i&carriage a&&ociated wit%
inva&ive te&t& &uc% a& a#niocente&i& and CAS =C%orionic Aillu& Sa#pling>.
.%e diagno&tic te&ting tec%ni<ue& #ar/et con&i&t& of /e, pla,er& &uc% a& 6io9Rad ;aboratorie&$
Agilent .ec%nologie&$ )er/in -l#er and Ario&a Diagno&tic&. Agilent .ec%nologie& and 6io9Rad
;aboratorie& are t%e leading pla,er& in diagno&tic te&ting tec%ni<ue& #ar/et becau&e of t%eir
do#inance in reagent& and in&tru#ent& #ar/et. 1aBor pla,er& of t%e &creening #et%od& #ar/et
are Se<ueno#$ :nc.$ :llu#ina$ :nc. and 0atera$ :nc. 7verall Se<ueno#$ :nc. and Aerinata ?ealt%
are t%e #aBor #ar/et pla,er& of t%e global prenatal and newborn genetic te&ting #ar/et becau&e
of t%eir initial product launc%e& in t%i& #ar/et.
.%e global prenatal and newborn genetic te&ting #ar/et i& &eg#ented a& follow&8
)renatal and 0ewborn Genetic .e&ting 1ar/et$ b, .ec%nolog,
Diagno&tic .ec%ni<ue&
)ol,#era&e C%ain Reaction =)CR>
2luore&cence :n9Situ ?,bridi*ation =2:S?>
Arra,9Co#parative Geno#ic ?,bridi*ation =aCG?>
Screening 1et%od&
0on9inva&ive )renatal .e&t& =1aterni.21 );US$ Aeri5$ ?ar#on,$ )anora#a$ 0:2.C$ )rena.e&t and
6a#bni .e&t>
1aternal Seru# Screening =1SS>
)renatal and 0ewborn Genetic .e&ting1ar/et$ b, Geograp%,
0ort% A#erica
-urope
Trans&arenc% Market Researc'
3
Prenatal and New-
born Genetic Testing
Market
A&ia9)aci5c
Re&t of t%e 4orld =Ro4>
.or Sa)ple Report /isit +n:
%ttp8++www.tran&parenc,#ar/etre&earc%.co#+&a#ple+&a#ple.p%pDEagFSGrepHidF1(II
,able o0 Content
Capter 1 -ntro!uction
111 Report Description
11" Mar2et Seg)entation
113 Researc Meto!olog%
11311 Sources
114 List o0 4bbre5iations
Capter " *6ecuti5e Su))ar%
"11 Mar2et Snapsot: 7lobal Prenatal an! &e'born 7enetic ,esting Mar2et 8"01" 9 "019:
"1" 7lobal Prenatal an! &e'born 7enetic ,esting Mar2et; b% Seg)ents; "01" 8USD Million:
Capter 3 Prenatal an! &e'born 7enetic ,esting Mar2et +5er5ie'
Trans&arenc% Market Researc'
I
,4$L* +. C+&,*&,
Prenatal and New-
born Genetic Testing
Market
311 -ntro!uction an! Mar2et De<nition
31" .uture Mar2et +utloo2
313 Regulator% an! Rei)burse)ent Scenario 0or Prenatal an! &e'born Screening
314 Mar2et D%na)ics
31411 Dri5ers
3141" Restraints
31413 Mar2et +pportunities
315 Porter=s .i5e .orces 4nal%sis: 7lobal Prenatal an! &e'born 7enetic ,esting Mar2et
31511 $argaining Po'er o0 Suppliers
3151" $argaining Po'er o0 $u%ers
31513 ,reat o0 Substitutes
31514 ,reat o0 &e' *ntrants
31515 Co)petiti5e Ri5alr%
31> Mar2et 4ttracti5eness 4nal%sis
Capter 4 Prenatal an! &e'born 7enetic ,esting Mar2et; b% ,ecnolog%
411 +5er5ie'
41111 7lobal Prenatal an! &e'born 7enetic ,esting Mar2et Re5enue; b% ,ecnolog%; "01" ?
"019 8USD Million:
41" Diagnostic ,ecni(ues
Trans&arenc% Market Researc'
3
Prenatal and New-
born Genetic Testing
Market
41"11 7lobal Diagnostic ,ecni(ues Mar2et Re5enue; b% ,%pes; "01" ? "019 8USD Million:
41"1" Pol%)erase Cain Reaction 8PCR:
41"13 .luorescence -n#Situ @%bri!iAation 8.-S@:
41"14 4rra%#Co)parati5e 7eno)ic @%bri!iAation 8aC7@:
413 Screening Meto!s
41311 7lobal Screening Meto!s Mar2et Re5enue; b% ,%pes; "01" ? "019 8USD Million:
4131" &on#in5asi5e Prenatal ,ests 8Materni,"1 PLUS; /eri<; @ar)on%; Panora)a; &-.,B;
Prena,est an! $a)bni ,est:
41313 Maternal Seru) Screening 8MSS:
Capter 5 Prenatal an! &e'born 7enetic ,esting Mar2et; b% 7eograp%
511 +5er5ie'
51111 7lobal Prenatal an! &e'born 7enetic ,esting Mar2et Re5enue; b% 7eograp%"01" ?
"019 8USD Million:
51" &ort 4)erica
51"11 &ort 4)erica Prenatal an! &e'born 7enetic ,esting Mar2et Re5enue; b%
,ecnolog%; "01" # "019 8USD Million:
51"1" &ort 4)erica Diagnostic ,ecni(ues Mar2et Re5enue; b% ,%pes; "01" # "019 8USD
Million:
51"13 &ort 4)erica Screening Meto!s Mar2et Re5enue; b% ,%pes; "01" # "019 8USD
Million:
Trans&arenc% Market Researc'

Prenatal and New-

born Genetic Testing
Market
513 *urope
51311 *urope Prenatal an! &e'born 7enetic ,esting Mar2et Re5enue; b% ,ecnolog%; "01" #
"019 8USD Million:
5131" *urope Diagnostic ,ecni(ues Mar2et Re5enue; b% ,%pes; "01" # "019 8USD Million:
51313 *urope Screening Meto!s Mar2et Re5enue; b% ,%pes; "01" # "019 8USD Million:
514 4sia # Paci<c
51411 4sia#Paci<c Prenatal an! &e'born 7enetic ,esting Mar2et Re5enue; b% ,ecnolog%;
"01" # "019 8USD Million:
5141" 4sia#Paci<c Diagnostic ,ecni(ues Mar2et Re5enue; b% ,%pes; "01" # "019 8USD
Million:
51413 4sia#Paci<c Screening Meto!s Mar2et Re5enue; b% ,%pes; "01" # "019 8USD Million:
515 Rest o0 te Corl! 8RoC:
51511 RoC Prenatal an! &e'born 7enetic ,esting Mar2et Re5enue; b% ,ecnolog%; "01" #
"019 8USD Million:
5151" RoC Diagnostic ,ecni(ues Mar2et Re5enue; b% ,%pes; "01" # "019 8USD Million:
51513 RoC Screening Meto!s Mar2et Re5enue; b% ,%pes; "01" # "019 8USD Million:
Capter > Co)petiti5e Lan!scape
>11 Mar2et Sare 4nal%sis; b% De% Pla%ers; "01" 8E:
Capter 7 Reco))en!ations
Trans&arenc% Market Researc'
(
Prenatal and New-
born Genetic Testing
Market
711 Mar2et Strateg% 0or Success
71111 .ocus on 0or)ing alliances 'it !iagnostic ser5ice pro5i!ers in 4sia#Paci<c countries
7111" *)pasis on i)pro5ing tecnolog% in or!er to increase accurac%; re!uce te !uration
o0 result generation an! price
71" $arriers an! .uture 4ssu)ptions
71"11 Lac2 o0 a'areness about prenatal an! ne'born genetic testing in so)e 4sian
countries
71"1" Regulator% co)pliance an! etical issues
Capter 8 Co)pan% Pro<les
811 4gilent ,ecnologies; -nc1
81111 Co)pan% +5er5ie'
8111" .inancial +5er5ie'
81113 Pro!uct Port0olio
81114 $usiness Strategies
81115 Recent De5elop)ents
81" 4riosa Diagnostics; -nc1
81"11 Co)pan% +5er5ie'
81"1" .inancial +5er5ie'
81"13 Pro!uct Port0olio
Trans&arenc% Market Researc'
'
Prenatal and New-
born Genetic Testing
Market
81"14 $usiness Strategies
81"15 Recent De5elop)ents
813 $io#Ra! Laboratories; -nc1
81311 Co)pan% +5er5ie'
8131" .inancial +5er5ie'
81313 Pro!uct Port0olio
81314 $usiness Strategies
81315 Recent De5elop)ents
814 -llu)ina; -nc1
81411 Co)pan% +5er5ie'
8141" .inancial Per0or)ance
81413 Pro!uct Port0olio
81414 $usiness Strategies
81415 Recent De5elop)ents
815 Laborator% Corporation o0 4)erica @ol!ings 8LabCorp:
81511 Co)pan% +5er5ie'
8151" .inancial +5er5ie'
81513 Pro!uct Port0olio
81514 $usiness Strategies
Trans&arenc% Market Researc'
!
Prenatal and New-
born Genetic Testing
Market
81515 Recent De5elop)ents
81> &atera; -nc1
81>11 Co)pan% +5er5ie'
81>1" .inancial +5er5ie'
81>13 Pro!uct Port0olio
81>14 $usiness Strategies
81>15 Recent De5elop)ents
817 Per2in*l)er; -nc1
81711 Co)pan% +5er5ie'
8171" .inancial +5er5ie'
81713 Pro!uct Port0olio
81714 $usiness Strategies
81715 Recent De5elop)ents
818 Se(ueno); -nc1
81811 Co)pan% +5er5ie'
8181" .inancial +5er5ie'
81813 Pro!uct Port0olio
81814 $usiness Strategies
81815 Recent De5elop)ents
Trans&arenc% Market Researc'
10
Prenatal and New-
born Genetic Testing
Market
.ran&parenc, 1ar/et Re&earc% i& a #ar/et intelligence co#pan, providing global bu&ine&& infor#ation
report& and &ervice&. 7ur exclu&ive blend of <uantitative foreca&ting and trend& anal,&i& provide& forward9
loo/ing in&ig%t for t%ou&and& of deci&ion #a/er&.
4e are privileged wit% %ig%l, experienced tea# of Anal,&t&$ Re&earc%er& and Con&ultant&$ w%o u&e
proprietar, data &ource& and variou& tool& and tec%ni<ue& to gat%er$ and anal,*e infor#ation. 7ur
bu&ine&& oJering& repre&ent t%e late&t and t%e #o&t reliable infor#ation indi&pen&able for bu&ine&&e& to
&u&tain a co#petitive edge.
Contact:
.ran&parenc, 1ar/et Re&earc%
!0 State Street$
Suite (00$
Alban,
0C 9 1220(
United State&
.el8 K1931'91'91030
USA 9 Canada .oll 2ree '933293I33
-#ail8 &ale&Ltran&parenc,#ar/etre&earc%.co#
4eb&ite8 %ttp8++www.tran&parenc,#ar/etre&earc%.co#+
Trans&arenc% Market Researc'
11
4bout Us